Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
TMO Quote, Financials, Valuation and Earnings
Last price:
$578.82
Seasonality move
:
6.45%
Day range:
$576.33 - $579.81
52-week range:
$385.46 - $610.97
Dividend yield:
0.3%
P/E ratio:
33.46x
P/S ratio:
5.03x
P/B ratio:
4.26x
Volume:
401K
Avg. volume:
1.7M
1-year change:
9.48%
Market cap:
$217.6B
Revenue:
$42.9B
EPS (TTM):
$17.31
Analysts' Opinion
-
Consensus RatingThermo Fisher Scientific, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 17 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $639.39, Thermo Fisher Scientific, Inc. has an estimated upside of 10.41% from its current price of $579.12.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $575.00 representing 0.71% downside risk from its current price of $579.12.
Fair Value
-
According to the consensus of 22 analysts, Thermo Fisher Scientific, Inc. has 10.41% upside to fair value with a price target of $639.39 per share.
TMO vs. S&P 500
-
Over the past 5 trading days, Thermo Fisher Scientific, Inc. has overperformed the S&P 500 by 1.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Thermo Fisher Scientific, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Thermo Fisher Scientific, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Thermo Fisher Scientific, Inc. reported revenues of $11.1B.
Earnings Growth
-
Thermo Fisher Scientific, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Thermo Fisher Scientific, Inc. reported earnings per share of $4.28.
Enterprise value:
249.8B
EV / Invested capital:
2.88x
Price / LTM sales:
5.03x
EV / EBIT:
30.43x
EV / Revenue:
5.71x
PEG ratio (5yr expected):
3.92x
EV / Free cash flow:
40.88x
Price / Operating cash flow:
35.96x
Enterprise value / EBITDA:
22.71x
Gross Profit (TTM):
$17.7B
Return On Assets:
6.56%
Net Income Margin (TTM):
15.03%
Return On Equity:
13.15%
Return On Invested Capital:
7.77%
Operating Margin:
19.37%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $43.4B | $42.4B | $43.7B | $10.6B | $11.1B | |
| Gross Profit | $16.9B | $16.8B | $17.7B | $4.3B | $4.6B | |
| Operating Income | $7.4B | $7.4B | $8.2B | $1.9B | $2.2B | |
| EBITDA | $10.9B | $10.6B | $11B | $2.6B | $2.8B | |
| Diluted EPS | $15.26 | $15.95 | $17.31 | $4.24 | $4.28 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $24.7B | $19.3B | $23.1B | $23.8B | $22.3B | |
| Total Assets | $73.6B | $90.5B | $97.1B | $100.4B | $103B | |
| Current Liabilities | $7.8B | $11.1B | $14.2B | $14.6B | $14.9B | |
| Total Liabilities | $34.9B | $46.8B | $51.6B | $51.3B | $51.9B | |
| Total Equity | $38.7B | $43.7B | $45.5B | $49.1B | $51.2B | |
| Total Debt | $21.7B | $29.2B | $35.3B | $35.3B | $35.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.2B | $9.1B | $7.7B | $2.2B | $2.2B | |
| Cash From Investing | -$5.3B | -$6.2B | -$4.9B | -$3.6B | -$4.1B | |
| Cash From Financing | $197M | -$4.6B | -$5.4B | -$1.2B | -$632M | |
| Free Cash Flow | $6.5B | $7.8B | $6.1B | $1.9B | $1.8B | |
TMO
Sector
Market Cap
$217.6B
$28M
Price % of 52-Week High
94.79%
51.03%
Dividend Yield
0.3%
0%
Shareholder Yield
2.49%
-1.54%
1-Year Price Total Return
9.48%
-17.48%
Beta (5-Year)
0.899
0.518
Dividend yield:
0.3%
Annualized payout:
$1.56
Payout ratio:
10.06%
Growth streak:
7 years
Technicals
8-day SMA
Buy
Level
$571.70
200-day SMA
Buy
Level
$483.86
Bollinger Bands (100)
Buy
Level
485.75 - 575.25
Chaikin Money Flow
Buy
Level
2.5M
20-day SMA
Buy
Level
$575.40
Relative Strength Index (RSI14)
Buy
Level
55.14
ADX Line
Buy
Level
14.92
Williams %R
Sell
Level
-5.5321
50-day SMA
Buy
Level
$570.70
MACD (12, 26)
Buy
Level
151.22
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
713.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.0672)
Buy
CA Score
(Annual)
Level (0.0187)
Buy
Beneish M-Score
(Annual)
Level (-2.5809)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.9214)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers’ needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company’s goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company’s history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.
Stock Forecast FAQ
In the current month, TMO has received 17 Buy ratings 5 Hold ratings, and 0 Sell ratings. The TMO average analyst price target in the past 3 months is $639.39.
-
Where Will Thermo Fisher Scientific, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Thermo Fisher Scientific, Inc. share price will rise to $639.39 per share over the next 12 months.
-
What Do Analysts Say About Thermo Fisher Scientific, Inc.?
Analysts are divided on their view about Thermo Fisher Scientific, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Thermo Fisher Scientific, Inc. is a Sell and believe this share price will drop from its current level to $575.00.
-
What Is Thermo Fisher Scientific, Inc.'s Price Target?
The price target for Thermo Fisher Scientific, Inc. over the next 1-year time period is forecast to be $639.39 according to 22 Wall Street analysts, 17 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is TMO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Thermo Fisher Scientific, Inc. is a Buy. 17 of 22 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TMO?
You can purchase shares of Thermo Fisher Scientific, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Thermo Fisher Scientific, Inc. shares.
-
What Is The Thermo Fisher Scientific, Inc. Share Price Today?
Thermo Fisher Scientific, Inc. was last trading at $578.82 per share. This represents the most recent stock quote for Thermo Fisher Scientific, Inc.. Yesterday, Thermo Fisher Scientific, Inc. closed at $579.12 per share.
-
How To Buy Thermo Fisher Scientific, Inc. Stock Online?
In order to purchase Thermo Fisher Scientific, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get TMO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TMO
Sector
P/E ratio
33.46x
23.89x
PEG ratio
3.92x
-0.01x
P/B ratio
4.26x
1.82x
Price / LTM sales
5.03x
1.60x
Growth Metrics
TMO
Sector
Revenue growth
4.94%
4.62%
Earnings growth
0.71%
10.88%
Revenue (5-year growth)
10.92%
6.5%
Earnings forecast
$5.50
-$0.21
Profitability
TMO
Sector
Profitability FY 2024
$17.7B
$3.5M
Return on invested capital
7.77%
-31.77%
Return on assets
6.56%
-27.96%
Return on equity
13.15%
-37.63%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Jan
29
Estimated Next Earnings Date
Jan
21
Balance Sheet
TMO
Sector
Total cash
$3.6B
$26.3M
Short term investments
$1.6B
$25.7M
Total assets
$97.3B
$78M
Long term debt
$35.7B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
